Jul 08, 2020 / 10:00AM GMT
Operator
Ladies and gentlemen, welcome to the Novozymes Conference Call. (Operator Instructions) And just to remind you, this conference call is being recorded. I'll start by handing over to Tobias Bjorklund, Head of Investor Relations. Please begin your meeting.
Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR
Thank you, operator, and thank you all for calling in with the short notice. From Novozymes, I'm joined here today by the entire management team as well as the rest of the Investor Relations team.
By now, everyone should have access to the company's trading update published earlier today. We have released this announcement ahead of schedule in accordance with the EU regulation, commonly referred to as the Market Abuse Regulation and because Novozymes has suspended its 2020 outlook. The announcement includes sales and organic sales growth for the first half year and the second quarter as well as a preliminary EBIT margin. We expect this call to take around 30 minutes, and we will have time for questions at the end. I
Q2 2020 Novozymes A/S Trading Update Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers